These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 9553173
21. Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma. Fröberg AC, de Jong M, Nock BA, Breeman WA, Erion JL, Maina T, Verdijsseldonck M, de Herder WW, van der Lugt A, Kooij PP, Krenning EP. Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1265-72. PubMed ID: 19266197 [Abstract] [Full Text] [Related]
22. Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo. Reubi JC, Waser B, Schaer JC, Laederach U, Erion J, Srinivasan A, Schmidt MA, Bugaj JE. Eur J Nucl Med; 1998 May; 25(5):481-90. PubMed ID: 9575243 [Abstract] [Full Text] [Related]
23. Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting. Kaloudi A, Nock BA, Krenning EP, Maina T, De Jong M. Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):287-302. PubMed ID: 26158215 [Abstract] [Full Text] [Related]
24. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors? Behr TM, Gratz S, Markus PM, Dunn RM, Hüfner M, Schauer A, Fischer M, Munz DL, Becker H, Becker W. Cancer; 1997 Dec 15; 80(12 Suppl):2436-57. PubMed ID: 9406695 [Abstract] [Full Text] [Related]
25. Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin. Laverman P, Roosenburg S, Gotthardt M, Park J, Oyen WJ, de Jong M, Hellmich MR, Rutjes FP, van Delft FL, Boerman OC. Eur J Nucl Med Mol Imaging; 2008 Feb 15; 35(2):386-92. PubMed ID: 17934729 [Abstract] [Full Text] [Related]
26. Preclinical evaluation of gastrin derivatives labelled with 111In: radiolabelling, affinity profile and pharmacokinetics in rats. Melicharova L, Laznickova A, Laznicek M. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec 15; 158(4):544-51. PubMed ID: 24108197 [Abstract] [Full Text] [Related]
27. Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patients. Maina T, Konijnenberg MW, KolencPeitl P, Garnuszek P, Nock BA, Kaloudi A, Kroselj M, Zaletel K, Maecke H, Mansi R, Erba P, von Guggenberg E, Hubalewska-Dydejczyk A, Mikolajczak R, Decristoforo C. Eur J Pharm Sci; 2016 Aug 25; 91():236-42. PubMed ID: 27185299 [Abstract] [Full Text] [Related]
28. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Zhou W, Povoski SP, Longnecker DS, Bell RH. Cancer Res; 1992 Dec 15; 52(24):6905-11. PubMed ID: 1458479 [Abstract] [Full Text] [Related]
29. Expression of cholecystokinin-B/gastrin receptors in medullary thyroid cancer. Amiri-Mosavi A, Ahlman H, Tisell LE, Wängberg B, Kölby L, Forssell-Aronsson E, Lundberg PA, Lindstedt G, Nilsson O. Eur J Surg; 1999 Jul 15; 165(7):628-31. PubMed ID: 10452255 [Abstract] [Full Text] [Related]
30. Diagnostic applications of radiolabeled peptides in nuclear endocrinology. Behr TM, Béhé M, Becker W. Q J Nucl Med; 1999 Sep 15; 43(3):268-80. PubMed ID: 10568142 [Abstract] [Full Text] [Related]
32. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC. Hum Gene Ther; 2007 Oct 15; 18(10):916-24. PubMed ID: 17931047 [Abstract] [Full Text] [Related]
33. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies. Behr TM, Béhé M, Löhr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W. Eur J Nucl Med; 2000 Jul 15; 27(7):753-65. PubMed ID: 10952487 [Abstract] [Full Text] [Related]
34. Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. Bardiès M, Bardet S, Faivre-Chauvet A, Peltier P, Douillard JY, Mahé M, Fiche M, Lisbona A, Giacalone F, Meyer P, Gautherot E, Rouvier E, Barbet J, Chatal JF. J Nucl Med; 1996 Nov 15; 37(11):1853-9. PubMed ID: 8917192 [Abstract] [Full Text] [Related]
35. Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies. von Guggenberg E, Rangger C, Sosabowski J, Laverman P, Reubi JC, Virgolini IJ, Decristoforo C. Mol Imaging Biol; 2012 Jun 15; 14(3):366-75. PubMed ID: 21732165 [Abstract] [Full Text] [Related]